139 related articles for article (PubMed ID: 37796634)
1. Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema: A Real-life Experience.
Baynova K; Cimbollek S; Quiralte J; García R; Lucena JM; Lasa Luaces E; Lara Jiménez MA; Alvarez Nieto J; Moreto J; González-Quevedo T
J Investig Allergol Clin Immunol; 2024 Jun; 34(3):198-199. PubMed ID: 37796634
[No Abstract] [Full Text] [Related]
2. Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks.
Craig T; Zuraw B; Longhurst H; Cicardi M; Bork K; Grattan C; Katelaris C; Sussman G; Keith PK; Yang W; Hébert J; Hanzlikova J; Staubach-Renz P; Martinez-Saguer I; Magerl M; Aygören-Pürsün E; Farkas H; Reshef A; Kivity S; Neri S; Crisan I; Caballero T; Baeza ML; Hernandez MD; Li H; Lumry W; Bernstein JA; Hussain I; Anderson J; Schwartz LB; Jacobs J; Manning M; Levy D; Riedl M; Christiansen S; Feuersenger H; Pragst I; Mycroft S; Pawaskar D; Jacobs I;
J Allergy Clin Immunol Pract; 2019; 7(6):1793-1802.e2. PubMed ID: 30772477
[TBL] [Abstract][Full Text] [Related]
3. Advances in Hereditary Angioedema: The Prevention of Angioedema Attacks With Subcutaneous C1-Inhibitor Replacement Therapy.
Lumry W; Templeton T; Omert L; Levy D
J Infus Nurs; 2020; 43(3):134-145. PubMed ID: 32287168
[TBL] [Abstract][Full Text] [Related]
4. Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate.
Zuraw BL; Cicardi M; Longhurst HJ; Bernstein JA; Li HH; Magerl M; Martinez-Saguer I; Rehman SM; Staubach P; Feuersenger H; Parasrampuria R; Sidhu J; Edelman J; Craig T
Allergy; 2015 Oct; 70(10):1319-28. PubMed ID: 26016741
[TBL] [Abstract][Full Text] [Related]
5. C1-esterase inhibitor (Cinryze
Gupta R; Balduzzi J; Davis-Lorton M
Immunotherapy; 2018 Jun; 10(8):635-642. PubMed ID: 29569504
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial.
Li HH; Mycroft S; Christiansen S; Wood DN; Feuersenger H; Pawaskar D; Jacobs I
Allergy Asthma Proc; 2018 Sep; 39(5):365-370. PubMed ID: 30107868
[TBL] [Abstract][Full Text] [Related]
7. Self-administration of intravenous C1 esterase inhibitor in hereditary angioedema.
Rizk C; Karsh J; Santucci S; Yang W
CMAJ; 2013 Jun; 185(9):791-2. PubMed ID: 23610020
[No Abstract] [Full Text] [Related]
8. Haegarda--a subcutaneous C1 esterase inhibitor for prevention of hereditary angioedema.
Med Lett Drugs Ther; 2018 Feb; 60(1541):39-40. PubMed ID: 29485978
[No Abstract] [Full Text] [Related]
9. Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings.
Craig T; Lumry W; Cicardi M; Zuraw B; Bernstein JA; Anderson J; Jacobs J; Riedl MA; Manning ME; Banerji A; Gower RG; Caballero T; Farkas H; Feuersenger H; Jacobs I; Machnig T; Longhurst H;
J Allergy Clin Immunol Pract; 2019; 7(6):2035-2038. PubMed ID: 30660873
[No Abstract] [Full Text] [Related]
10. Usefulness of C1 esterase inhibitor protein concentrate in the management of hereditary angioedema of oropharyngeal tissue.
Yigit M; Sogut O; Lisar H; Yigit E
Niger J Clin Pract; 2018 Apr; 21(4):531-533. PubMed ID: 29607870
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema.
Valerieva A; Staevska M; Jesenak M; Hrubiskova K; Sobotkova M; Zachova R; Hakl R; Andrejevic S; Suiter T; Grivcheva-Panovska V; Karadza-Lapic L; Soteres D; Shapiro R; Rumbyrt J; Tachdjian R; Mehta V; Hsu FI; Zanichelli A
J Allergy Clin Immunol Pract; 2020 Feb; 8(2):799-802. PubMed ID: 31437566
[No Abstract] [Full Text] [Related]
12. Subcutaneous plasma-derived C1 inhibitor for long-term prophylaxis during pregnancy and breast-feeding in a patient with factor XII hereditary angioedema.
Herraez L; Álvarez Sala P; Mielgo R
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2587-2588. PubMed ID: 37121510
[No Abstract] [Full Text] [Related]
13. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
[TBL] [Abstract][Full Text] [Related]
14. Preventive Treatment of Hereditary Angioedema: A Review of Phase III Clinical Trial Data for Subcutaneous C1 Inhibitor and Relevance for Patient Management.
West JB; Poarch K; Lumry WR
Clin Ther; 2021 Dec; 43(12):2154-2166.e1. PubMed ID: 34879971
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic Therapy for Hereditary Angioedema.
Longhurst H; Zinser E
Immunol Allergy Clin North Am; 2017 Aug; 37(3):557-570. PubMed ID: 28687109
[TBL] [Abstract][Full Text] [Related]
16. Hereditary angioedema and pregnancy: a successful outcome using C1 esterase inhibitor concentrate.
Gorman PJ
Can Fam Physician; 2008 Mar; 54(3):365-6. PubMed ID: 18337530
[No Abstract] [Full Text] [Related]
17. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
Lumry WR; Zuraw B; Cicardi M; Craig T; Anderson J; Banerji A; Bernstein JA; Caballero T; Farkas H; Gower RG; Keith PK; Levy DS; Li HH; Magerl M; Manning M; Riedl MA; Lawo JP; Prusty S; Machnig T; Longhurst H;
Orphanet J Rare Dis; 2021 Feb; 16(1):86. PubMed ID: 33588897
[TBL] [Abstract][Full Text] [Related]
18. Long-term prophylaxis with C1-inhibitor concentrate in patients with hereditary angioedema.
Pedrosa M; Lobera T; Panizo C; Jurado J; Caballero T
J Investig Allergol Clin Immunol; 2014; 24(4):271-3. PubMed ID: 25219111
[No Abstract] [Full Text] [Related]
19. Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy.
Moldovan D; Bernstein JA; Hakl R; Porebski G; Poarch K; Lumry WR; Relan A
J Allergy Clin Immunol Pract; 2019; 7(8):2938-2940. PubMed ID: 31170541
[No Abstract] [Full Text] [Related]
20. Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric Patients with Hereditary Angioedema.
Levy D; Caballero T; Hussain I; Reshef A; Anderson J; Baker J; Schwartz LB; Cicardi M; Prusty S; Feuersenger H; Pragst I; Manning ME
Pediatr Allergy Immunol Pulmonol; 2020 Sep; 33(3):136-141. PubMed ID: 32953229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
